Poland Is 'the Place to Be' for College of Medicine Fulbright Scholar
Janusz Suszkiw, PhD, a professor in the
molecular and cellular physiology
department in the College of Medicine, is one of four UC faculty members to receive a Fulbright grant, the U.S. governments prestigious international educational exchange program, for the 200506 academic year.
The Polish-born neuroscientist will do research in his homeland at the Nencki Institute of the Polish Academy of Sciences, Warsaw, and at the Gdansk Medical Academy.
The fact that hes going to Poland, says Suszkiw, who has already done sabbaticals at the
world-renowned Max Planck Institute in Göttingen, Germany, and at the National Institutes of Health in Bethesda, Md., is largely coincidental. His area of research is in the causes of neuronal degeneration, compensatory phenomena and pharmacological interventions to lessen neurodegenerative changes in the brain, whether induced by toxins in the environment lead poisoning in children, for exampleand ageing-related diseases like Alzheimers and Parkinsons.
And for sheer excellence of research in this fieldespecially new discoveries about the role of what are known as the extracellular matrix metalloproteinases in development, neurodegeneration and brain repairPoland is the place to be, he says.
Suszkiw, who came to the United States as a teenager, worked his way through school, earning his undergraduate degree in chemistry and a masters and PhD in biochemistry at George Washington University, followed by postdoctoral training in neurobiology at Cornell.
The son of a physician, Suszkiw says he always wanted to do biomedical research.
I was always of a philosophical bent, he said. As a kid, I wanted to know how the universe worked. But before understanding the universe, you have to try to figure out how the brain works, because thats what interprets the universe.
After being engaged in basic neurobiological studies, a personal experience with the ravages of Alzheimers disease in his mother prompted Suszkiw to switch his research focus to neurodegenerative diseases. Studying the mechanisms of neurodegeneration and brain repair, he says, actually is another way to learn how the normal brain works but, more important, it has the added advantage that it may lead to potential therapeutic applications.
The other UC Fulbright recipients were Vanessa Kay Allen-Brown, associate professor in Educational Studies, who will go to Cairo University; Katharina Gerstenberger, associate professor in German Studies, who toured throughout Germany last summer; and Daniel Oerther, assistant professor of environmental engineering, whose Fulbright will take him to the Manipal Academy of Higher Education in Manipal, India.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.